author-photo

Montserrat Muñoz

University of Barcelona

141

Papers

3287

Citations

Citation Trend

Filter By

Papers (104) Sort By

Journal Conference Others

Independent validation of the PAM50-based Chemo-Endocrine Score in hormonal receptor positive HER2-positive breast cancer treated with neoadjuvant therapy.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Psoriasis: From Pathogenesis to Pharmacological and Nano-Technological-Based Therapeutics

2021 International Journal of Molecular Sciences
Show All
- Source
- Cite
- Save
Citations (3)
Genetic profiling across multiple cancer types using molecular prescreening comprehensive gene panels offered by clinical trials (CT).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract OT-17-01: Solti-1903 hope: Real-world clinical practice study to assess the impact of using comprehensive genomic data on the next treatment decision making-choice in patients with locally advanced or metastatic breast cancer in Spain

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract OT-13-04: Solti-1716. Targeting non-Luminal disease by PAM50 with pembrolizumab + paclitaxel in Hormone Receptor-positive/HER2-negative advanced/metastatic breast cancer patients who have progressed on or after CDK 4/6 inhibitor treatment (TATEN trial)

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Abstract PS18-11: Molecular characterization of advanced breast cancer according to site of metastasis

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast Cancer.

2021 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Author response for "Gene expression profiles of breast cancer metastasis according to organ site"

2021
Show All
- Source
- Cite
- Save
Citations (0)
Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive metastatic breast cancer: Patient-reported outcomes in the PEARL study.

2021 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PS2-01: Plk1 expression & efficacy of palbociclib in advanced hormonal receptor-positive breast cancer patients from PEARL study (GEICAM 2012-03)

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)